Advancement of Biomaterial-Based Postoperative Adhesion Barriers

Area of Science:

• Biomaterials Science
• Surgical Innovation
• Regenerative Medicine

Background:

• Postoperative peritoneal adhesions (PPA) are a common complication following abdominal surgery, leading to significant morbidity including intestinal obstruction and infertility.
• Current clinical strategies involve various antiadhesion materials, including films, sprays, hydrogels, powders, and solutions, derived from both natural and synthetic biomaterials.
• The development of effective antiadhesion therapies is crucial for improving patient outcomes and reducing healthcare costs associated with PPA-related complications.

Purpose of the Study:

• To provide a comprehensive overview of the current progress in the field of antiadhesion materials and animal models for preventing postoperative peritoneal adhesions.
• To review the diverse range of biomaterials utilized in antiadhesion strategies and the various animal models employed for efficacy evaluation.
• To identify existing challenges and discuss future directions for the development of improved antiadhesion materials.

Main Methods:

• Literature review of studies on biomaterials for antiadhesion applications.
• Analysis of different types of antiadhesion materials, including films, sprays, hydrogels, powders, and solutions.
• Examination of various animal models used for evaluating antiadhesion efficacy, such as cecum abrasion and hepatectomy models.

Main Results:

• A wide array of natural and synthetic biomaterials, including alginate, hyaluronan, cellulose, starch, chondroitin sulfate, polyethylene glycol, and polylactic acid, are being investigated for PPA prevention.
• Established animal models like the cecum abrasion and unitary horn models, alongside a newly developed hepatectomy-based model, are used to assess the efficacy of antiadhesion barriers.
• Significant research efforts are focused on developing novel antiadhesion materials and refining existing ones to enhance their performance and clinical applicability.

Conclusions:

• The field of antiadhesion materials and animal models for PPA prevention is dynamic, with continuous innovation in biomaterial development and model systems.
• Addressing current limitations in biomaterial design and animal model relevance is essential for translating research findings into effective clinical antiadhesion therapies.
• Further research is needed to overcome challenges and develop superior antiadhesion materials that can significantly reduce the incidence and impact of postoperative peritoneal adhesions.